GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Guobang Pharma Ltd (SHSE:605507) » Definitions » Gross-Profit-to-Asset %

Guobang Pharma (SHSE:605507) Gross-Profit-to-Asset % : 13.91% (As of Mar. 2025)


View and export this data going back to 2021. Start your Free Trial

What is Guobang Pharma Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Guobang Pharma's annualized Gross Profit for the quarter that ended in Mar. 2025 was ¥1,523 Mil. Guobang Pharma's average Total Assets over the quarter that ended in Mar. 2025 was ¥10,948 Mil. Therefore, Guobang Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 was 13.91%.


Guobang Pharma Gross-Profit-to-Asset % Historical Data

The historical data trend for Guobang Pharma's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Guobang Pharma Gross-Profit-to-Asset % Chart

Guobang Pharma Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 27.86 20.85 19.04 12.91 13.93

Guobang Pharma Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 14.15 15.70 14.94 11.83 13.91

Competitive Comparison of Guobang Pharma's Gross-Profit-to-Asset %

For the Drug Manufacturers - Specialty & Generic subindustry, Guobang Pharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Guobang Pharma's Gross-Profit-to-Asset % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Guobang Pharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Guobang Pharma's Gross-Profit-to-Asset % falls into.


;
;

Guobang Pharma Gross-Profit-to-Asset % Calculation

Guobang Pharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=1472.727/( (10361.635+10780.436)/ 2 )
=1472.727/10571.0355
=13.93 %

Guobang Pharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2025 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Mar. 2025 )/( (Total Assets (Q: Dec. 2024 )+Total Assets (Q: Mar. 2025 ))/ count )
=1522.904/( (10780.436+11114.684)/ 2 )
=1522.904/10947.56
=13.91 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2025) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Guobang Pharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Guobang Pharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Guobang Pharma Business Description

Traded in Other Exchanges
N/A
Address
No. 60, Xingmei Avenue, Provincial High-tech Industrial Park, Zhejiang Province, Xinchang, CHN, 312500
Guobang Pharma Ltd is engaged in the research and development, production and sales of related products in the field of medicine and animal health products.

Guobang Pharma Headlines

No Headlines